SCHEMBL29396999

SCHEMBL29396999

CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCN

nearest known ligand 0.87

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ NAA50 Q9GZZ1 2/20 0.85
▸ CHAT P28329 2/20 0.82
▸ EP300 Q09472 3/20 0.80
▸ KAT5 Q92993 2/20 0.80
▸ AURKA O14965 2/20 0.80
▸ KAT2B Q92831 1/20 0.80
▸ CREBBP Q92793 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL284786 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
SCHEMBL18918369 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
SCHEMBL28216089 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
SCHEMBL28041178 1.00 NAA50 (0.85) NAA50CHATEP300KAT5AURKA
SCHEMBL19693052 0.99 NAA50 (0.86) NAA50CHATEP300KAT5AURKA
SCHEMBL15299842 0.99 NAA50 (0.86) NAA50CHATEP300KAT5AURKA
SCHEMBL29530678 0.98 NAA50 (0.87) NAA50CHATEP300KAT5AURKA
SCHEMBL22556110 0.98 NAA50 (0.87) NAA50CHATEP300KAT5AURKA
SCHEMBL59962 0.98 NAA50 (0.87) NAA50CHATEP300KAT5AURKA
SCHEMBL59721 0.96 NAA50 (0.88) NAA50CHATEP300KAT5AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577594-B2 Engineered microorganisms and methods for improved aldehyde dehydrogenase activity GENOMATICA, INC. (US) 2026-03-17 — — US claimed
EP-4642908-A2 LIGASE AND DEHYDROGENASE VARIANTS AND METHODS OF USE Genomatica, Inc. (US) 2025-11-05 — — EP claimed
WO-2024145507-A2 LIGASE AND DEHYDROGENASE VARIANTS AND METHODS OF USE GENOMATICA, INC. (US) 2024-07-04 — — WO claimed
EP-4051657-A1 MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS Genomatica, Inc. (US) 2022-09-07 — — EP claimed
EP-4048781-A1 MICROORGANISMS AND METHODS FOR INCREASING CO-FACTORS Genomatica, Inc. (US) 2022-08-31 — — EP claimed
US-20220235385-A1 ENGINEERED MICROORGANISMS AND METHODS FOR IMPROVED ALDEHYDE DEHYDROGENASE ACTIVITY AGAIN BIO APS (DK) 2022-07-28 — — US claimed
EP-3959310-A1 ENGINEERED TRANSAMINASE AND METHODS OF MAKING AND USING Genomatica, Inc. (US) 2022-03-02 — — EP claimed
EP-3959327-A1 ENGINEERED TRANS-ENOYL COA REDUCTASE AND METHODS OF MAKING AND USING Genomatica, Inc. (US) 2022-03-02 — — EP claimed
US-12577594-B2 Engineered microorganisms and methods for improved aldehyde dehydrogenase activity GENOMATICA, INC. (US) 2026-03-17 — — US disclosed
US-12529078-B2 Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis GENOMATICA, INC. (US) 2026-01-20 — — US disclosed
EP-4662192-A1 MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS Genomatica, Inc. (US) 2025-12-17 — — EP disclosed
EP-4642908-A2 LIGASE AND DEHYDROGENASE VARIANTS AND METHODS OF USE Genomatica, Inc. (US) 2025-11-05 — — EP disclosed
US-20250305013-A1 Methods and Compositions for Making Amide Compounds GENOMATICA, INC. (US) 2025-10-02 — — US disclosed
US-20240294950-A1 MICROORGANISMS AND METHODS FOR IMPROVING PRODUCT YIELDS ON METHANOL USING ACETYL-COA SYNTHESIS AGAIN BIO APS (DK) 2024-09-05 — — US disclosed
EP-4048781-A1 MICROORGANISMS AND METHODS FOR INCREASING CO-FACTORS Genomatica, Inc. (US) 2022-08-31 — — EP disclosed
US-20220235385-A1 ENGINEERED MICROORGANISMS AND METHODS FOR IMPROVED ALDEHYDE DEHYDROGENASE ACTIVITY AGAIN BIO APS (DK) 2022-07-28 — — US disclosed
WO-2022155554-A1 METHODS AND COMPOSITIONS FOR MAKING AMIDE COMPOUNDS GENOMATICA, INC. (US) 2022-07-21 — — WO disclosed
CN-114341344-A Engineered microorganisms and methods for improving aldehyde dehydrogenase activity 基因组股份公司 2022-04-12 — — CN disclosed
EP-3959310-A1 ENGINEERED TRANSAMINASE AND METHODS OF MAKING AND USING Genomatica, Inc. (US) 2022-03-02 — — EP disclosed
EP-3959327-A1 ENGINEERED TRANS-ENOYL COA REDUCTASE AND METHODS OF MAKING AND USING Genomatica, Inc. (US) 2022-03-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12529078-B2 Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis ALDOA, FDPS, DERA NAA50 298/4885CHAT 1363/4885EP300 1390/4885
US-12577594-B2 Engineered microorganisms and methods for improved aldehyde dehydrogenase activity ACADM, ALDH7A1, ADSL NAA50 211/4885CHAT 350/4885EP300 1233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback